25 XP   0   0   10

Klaria Pharma Holding AB
Buy, Hold or Sell?

Let's analyse Klaria together

PenkeI guess you are interested in Klaria Pharma Holding AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Klaria Pharma Holding AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Klaria Pharma Holding AB

I send you an email if I find something interesting about Klaria Pharma Holding AB.

Quick analysis of Klaria (30 sec.)










What can you expect buying and holding a share of Klaria? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.48
Expected worth in 1 year
kr0.58
How sure are you?
26.5%

+ What do you gain per year?

Total Gains per Share
kr0.11
Return On Investment
25.9%

For what price can you sell your share?

Current Price per Share
kr0.41
Expected price per share
kr0.235 - kr0.424
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Klaria (5 min.)




Live pricePrice per Share (EOD)

kr0.41

Intrinsic Value Per Share

kr-0.27 - kr-0.18

Total Value Per Share

kr0.21 - kr0.29

2. Growth of Klaria (5 min.)




Is Klaria growing?

Current yearPrevious yearGrowGrow %
How rich?$4.8m$5.7m$472.5k7.6%

How much money is Klaria making?

Current yearPrevious yearGrowGrow %
Making money-$945.9k-$2.2m$1.3m140.9%
Net Profit Margin-603.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Klaria (5 min.)




3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Klaria? (5 min.)

Welcome investor! Klaria's management wants to use your money to grow the business. In return you get a share of Klaria.

What can you expect buying and holding a share of Klaria?

First you should know what it really means to hold a share of Klaria. And how you can make/lose money.

Speculation

The Price per Share of Klaria is kr0.412. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Klaria.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Klaria, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.48. Based on the TTM, the Book Value Change Per Share is kr0.03 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Klaria.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-2.4%-0.01-2.2%-0.02-4.9%-0.01-2.6%-0.01-1.8%
Usd Book Value Change Per Share-0.01-2.2%0.000.6%-0.01-3.1%0.00-1.0%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-2.2%0.000.6%-0.01-3.1%0.00-1.0%0.000.3%
Usd Price Per Share0.06-0.08-0.47-0.53-0.59-
Price to Earnings Ratio-1.47--2.32--6.25--16.69--34.61-
Price-to-Total Gains Ratio-6.39--6.22-40.02--31.16--106.33-
Price to Book Ratio1.25-1.30-8.70-6.85-6.01-
Price-to-Total Gains Ratio-6.39--6.22-40.02--31.16--106.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.039758
Number of shares25152
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (25152 shares)64.82-103.46
Gains per Year (25152 shares)259.26-413.82
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102592490-414-424
205195080-828-838
307787670-1241-1252
40103710260-1655-1666
50129612850-2069-2080
60155615440-2483-2494
70181518030-2897-2908
80207420620-3311-3322
90233323210-3724-3736
100259325800-4138-4150

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.033.00.02.9%1.033.00.02.9%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%9.025.00.026.5%9.025.00.026.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.034.00.0%0.00.034.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%9.025.00.026.5%9.025.00.026.5%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Klaria

About Klaria Pharma Holding AB

Klaria Pharma Holding AB (publ.) operates as a pharmaceutical company. It develops Sumatriptan for the treatment of migraine. The company also develops Epinephrine/Adrenaline, which is in Phase I clinical trial for the treatment of acute allergic reaction. In addition, its pre-clinical product is Sirolimus for prevention of organ transplant rejection. Further, the company focuses on the commercialization of cannabis/cannabinoids. Klaria Pharma Holding AB (publ.) was incorporated in 2014 and is headquatered in Uppsala, Sweden.

Fundamental data was last updated by Penke on 2024-02-17 17:50:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Klaria Pharma Holding AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Klaria earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Klaria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1,745.6% means that kr-17.46 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Klaria Pharma Holding AB:

  • The MRQ is -1,745.6%. The company is making a huge loss. -2
  • The TTM is -603.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,745.6%TTM-603.0%-1,142.5%
TTM-603.0%YOY--603.0%
TTM-603.0%5Y-980.2%+377.2%
5Y-980.2%10Y-578.2%-402.0%
1.1.2. Return on Assets

Shows how efficient Klaria is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Klaria to the Drug Manufacturers - Specialty & Generic industry mean.
  • -14.2% Return on Assets means that Klaria generated kr-0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Klaria Pharma Holding AB:

  • The MRQ is -14.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-14.2%TTM-10.6%-3.6%
TTM-10.6%YOY-21.6%+11.0%
TTM-10.6%5Y-10.9%+0.3%
5Y-10.9%10Y-7.2%-3.7%
1.1.3. Return on Equity

Shows how efficient Klaria is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Klaria to the Drug Manufacturers - Specialty & Generic industry mean.
  • -21.3% Return on Equity means Klaria generated kr-0.21 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Klaria Pharma Holding AB:

  • The MRQ is -21.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.3%TTM-15.6%-5.7%
TTM-15.6%YOY-39.4%+23.7%
TTM-15.6%5Y-16.2%+0.5%
5Y-16.2%10Y-10.3%-5.8%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Klaria Pharma Holding AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Klaria is operating .

  • Measures how much profit Klaria makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Klaria to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -1,556.5% means the company generated kr-15.57  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Klaria Pharma Holding AB:

  • The MRQ is -1,556.5%. The company is operating very inefficient. -2
  • The TTM is -520.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,556.5%TTM-520.7%-1,035.8%
TTM-520.7%YOY--520.7%
TTM-520.7%5Y-963.8%+443.0%
5Y-963.8%10Y-568.5%-395.2%
1.2.2. Operating Ratio

Measures how efficient Klaria is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 16.57 means that the operating costs are kr16.57 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Klaria Pharma Holding AB:

  • The MRQ is 16.565. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.915. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ16.565TTM5.915+10.650
TTM5.915YOY-+5.915
TTM5.9155Y9.554-3.639
5Y9.55410Y5.668+3.886
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Klaria Pharma Holding AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Klaria is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.19 means the company has kr0.19 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Klaria Pharma Holding AB:

  • The MRQ is 0.189. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.584. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.189TTM0.584-0.395
TTM0.584YOY0.454+0.130
TTM0.5845Y0.831-0.248
5Y0.83110Y10.085-9.254
1.3.2. Quick Ratio

Measures if Klaria is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Klaria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.19 means the company can pay off kr0.19 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Klaria Pharma Holding AB:

  • The MRQ is 0.189. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.459. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.189TTM0.459-0.271
TTM0.459YOY0.454+0.006
TTM0.4595Y0.791-0.332
5Y0.79110Y9.863-9.072
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Klaria Pharma Holding AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Klaria assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Klaria to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.33 means that Klaria assets are financed with 33.3% credit (debt) and the remaining percentage (100% - 33.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Klaria Pharma Holding AB:

  • The MRQ is 0.333. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.312. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.333TTM0.312+0.021
TTM0.312YOY0.451-0.138
TTM0.3125Y0.269+0.044
5Y0.26910Y0.163+0.105
1.4.2. Debt to Equity Ratio

Measures if Klaria is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Klaria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 50.0% means that company has kr0.50 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Klaria Pharma Holding AB:

  • The MRQ is 0.500. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.460. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.500TTM0.460+0.040
TTM0.460YOY0.856-0.396
TTM0.4605Y0.412+0.047
5Y0.41210Y0.248+0.164
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Klaria Pharma Holding AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Klaria generates.

  • Above 15 is considered overpriced but always compare Klaria to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.47 means the investor is paying kr-1.47 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Klaria Pharma Holding AB:

  • The EOD is -1.015. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.469. Based on the earnings, the company is expensive. -2
  • The TTM is -2.324. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.015MRQ-1.469+0.453
MRQ-1.469TTM-2.324+0.856
TTM-2.324YOY-6.245+3.921
TTM-2.3245Y-16.688+14.364
5Y-16.68810Y-34.615+17.927
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Klaria Pharma Holding AB:

  • The EOD is -1.507. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.181. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.949. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.507MRQ-2.181+0.673
MRQ-2.181TTM-3.949+1.768
TTM-3.949YOY-12.724+8.775
TTM-3.9495Y24.547-28.496
5Y24.54710Y-10.820+35.368
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Klaria is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Klaria Pharma Holding AB:

  • The EOD is 0.866. Based on the equity, the company is cheap. +2
  • The MRQ is 1.252. Based on the equity, the company is underpriced. +1
  • The TTM is 1.300. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.866MRQ1.252-0.387
MRQ1.252TTM1.300-0.048
TTM1.300YOY8.702-7.402
TTM1.3005Y6.854-5.554
5Y6.85410Y6.009+0.845
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Klaria Pharma Holding AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0930.027-450%-0.131+41%-0.043-54%0.014-767%
Book Value Per Share--0.4760.606-21%0.560-15%0.778-39%1.081-56%
Current Ratio--0.1890.584-68%0.454-58%0.831-77%10.085-98%
Debt To Asset Ratio--0.3330.312+7%0.451-26%0.269+24%0.163+104%
Debt To Equity Ratio--0.5000.460+9%0.856-42%0.412+21%0.248+102%
Dividend Per Share----0%-0%-0%-0%
Eps---0.101-0.092-9%-0.211+108%-0.109+8%-0.077-25%
Free Cash Flow Per Share---0.068-0.069+0%-0.126+85%-0.066-4%-0.051-26%
Free Cash Flow To Equity Per Share---0.062-0.010-83%-0.045-27%0.000-26211%0.002-2769%
Gross Profit Margin--1.0871.079+1%1.019+7%1.052+3%1.110-2%
Intrinsic Value_10Y_max---0.183--------
Intrinsic Value_10Y_min---0.270--------
Intrinsic Value_1Y_max---0.279--------
Intrinsic Value_1Y_min---0.275--------
Intrinsic Value_3Y_max---0.641--------
Intrinsic Value_3Y_min---0.616--------
Intrinsic Value_5Y_max---0.762--------
Intrinsic Value_5Y_min---0.724--------
Market Cap43878412.000-45%63474596.00084748170.750-25%519991132.500-88%583108950.150-89%651231688.324-90%
Net Profit Margin---17.456-6.030-65%--100%-9.802-44%-5.782-67%
Operating Margin---15.565-5.207-67%--100%-9.638-38%-5.685-63%
Operating Ratio--16.5655.915+180%-+100%9.554+73%5.668+192%
Pb Ratio0.866-45%1.2521.300-4%8.702-86%6.854-82%6.009-79%
Pe Ratio-1.015+31%-1.469-2.324+58%-6.245+325%-16.688+1036%-34.615+2257%
Price Per Share0.412-45%0.5960.796-25%4.883-88%5.475-89%6.115-90%
Price To Free Cash Flow Ratio-1.507+31%-2.181-3.949+81%-12.724+483%24.547-109%-10.820+396%
Price To Total Gains Ratio-4.414+31%-6.385-6.216-3%40.022-116%-31.158+388%-106.326+1565%
Quick Ratio--0.1890.459-59%0.454-58%0.791-76%9.863-98%
Return On Assets---0.142-0.106-25%-0.216+52%-0.109-24%-0.072-49%
Return On Equity---0.213-0.156-27%-0.394+85%-0.162-24%-0.103-51%
Total Gains Per Share---0.0930.027-450%-0.131+41%-0.043-54%0.014-767%
Usd Book Value--4891295.5006226927.875-21%5754367.375-15%7993756.025-39%11110050.676-56%
Usd Book Value Change Per Share---0.0090.003-450%-0.013+41%-0.004-54%0.001-767%
Usd Book Value Per Share--0.0460.058-21%0.054-15%0.075-39%0.104-56%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.010-0.009-9%-0.020+108%-0.011+8%-0.007-25%
Usd Free Cash Flow---702230.500-704546.500+0%-1296742.875+85%-677280.425-4%-519834.147-26%
Usd Free Cash Flow Per Share---0.007-0.007+0%-0.012+85%-0.006-4%-0.005-26%
Usd Free Cash Flow To Equity Per Share---0.006-0.001-83%-0.004-27%0.000-26211%0.000-2769%
Usd Market Cap4234266.758-45%6125298.5148178198.477-25%50179144.286-88%56270013.689-89%62843857.923-90%
Usd Price Per Share0.040-45%0.0580.077-25%0.471-88%0.528-89%0.590-90%
Usd Profit---1042682.500-945917.125-9%-2278340.875+119%-1144813.275+10%-798983.103-23%
Usd Revenue--59733.500225713.500-74%-+100%65518.675-9%44997.382+33%
Usd Total Gains Per Share---0.0090.003-450%-0.013+41%-0.004-54%0.001-767%
 EOD+3 -5MRQTTM+6 -28YOY+18 -165Y+8 -2610Y+4 -30

3.2. Fundamental Score

Let's check the fundamental score of Klaria Pharma Holding AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.015
Price to Book Ratio (EOD)Between0-10.866
Net Profit Margin (MRQ)Greater than0-17.456
Operating Margin (MRQ)Greater than0-15.565
Quick Ratio (MRQ)Greater than10.189
Current Ratio (MRQ)Greater than10.189
Debt to Asset Ratio (MRQ)Less than10.333
Debt to Equity Ratio (MRQ)Less than10.500
Return on Equity (MRQ)Greater than0.15-0.213
Return on Assets (MRQ)Greater than0.05-0.142
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Klaria Pharma Holding AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.543
Ma 20Greater thanMa 500.502
Ma 50Greater thanMa 1000.529
Ma 100Greater thanMa 2000.499
OpenGreater thanClose0.381
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in SEK. All numbers in thousands.

Summary
Total Assets76,016
Total Liabilities25,329
Total Stockholder Equity50,689
 As reported
Total Liabilities 25,329
Total Stockholder Equity+ 50,689
Total Assets = 76,016

Assets

Total Assets76,016
Total Current Assets4,780
Long-term Assets71,236
Total Current Assets
Cash And Cash Equivalents 2,280
Net Receivables 2,500
Total Current Assets  (as reported)4,780
Total Current Assets  (calculated)4,780
+/-0
Long-term Assets
Property Plant Equipment 546
Intangible Assets 70,690
Long-term Assets  (as reported)71,236
Long-term Assets  (calculated)71,236
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities25,327
Long-term Liabilities2
Total Stockholder Equity50,689
Total Current Liabilities
Total Current Liabilities  (as reported)25,327
Total Current Liabilities  (calculated)0
+/- 25,327
Long-term Liabilities
Long-term Liabilities  (as reported)2
Long-term Liabilities  (calculated)0
+/- 2
Total Stockholder Equity
Common Stock1,775
Retained Earnings -26,313
Other Stockholders Equity 75,227
Total Stockholder Equity (as reported)50,689
Total Stockholder Equity (calculated)50,689
+/-0
Other
Capital Stock1,775
Cash and Short Term Investments 2,280
Common Stock Shares Outstanding 106,501
Liabilities and Stockholders Equity 76,016
Net Debt -2,280
Net Invested Capital 50,689
Net Working Capital -20,547
Property Plant and Equipment Gross 546



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-31
> Total Assets 
0
179,587
178,958
176,882
173,631
168,694
164,852
162,033
159,619
162,112
160,594
155,870
152,546
147,290
143,844
106,255
105,192
108,375
110,150
101,727
127,685
128,289
124,619
132,405
146,559
136,097
119,184
118,309
117,506
101,726
91,420
120,271
95,476
85,383
76,016
76,01685,38395,476120,27191,420101,726117,506118,309119,184136,097146,559132,405124,619128,289127,685101,727110,150108,375105,192106,255143,844147,290152,546155,870160,594162,112159,619162,033164,852168,694173,631176,882178,958179,5870
   > Total Current Assets 
0
49,643
48,771
46,813
43,562
38,562
34,723
31,908
29,432
23,301
21,798
18,078
14,761
9,511
6,070
9,557
9,745
15,450
10,108
4,183
18,206
22,168
21,855
32,999
49,877
42,139
27,814
27,803
29,757
16,694
9,192
40,758
18,721
11,388
4,780
4,78011,38818,72140,7589,19216,69429,75727,80327,81442,13949,87732,99921,85522,16818,2064,18310,10815,4509,7459,5576,0709,51114,76118,07821,79823,30129,43231,90834,72338,56243,56246,81348,77149,6430
       Cash And Cash Equivalents 
0
49,418
48,440
45,633
41,912
37,376
33,804
31,100
28,447
22,266
20,867
17,098
13,373
8,327
5,074
7,959
8,709
14,435
8,890
2,917
16,443
19,789
19,287
31,251
48,229
39,688
25,866
25,491
22,990
7,288
0
16,761
13,056
8,861
2,280
2,2808,86113,05616,76107,28822,99025,49125,86639,68848,22931,25119,28719,78916,4432,9178,89014,4358,7097,9595,0748,32713,37317,09820,86722,26628,44731,10033,80437,37641,91245,63348,44049,4180
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,015
1,218
712
1,763
2,379
2,568
769
1,648
2,451
1,948
2,312
6,767
9,406
2,467
2,210
5,665
2,527
2,500
2,5002,5275,6652,2102,4679,4066,7672,3121,9482,4511,6487692,5682,3791,7637121,2181,01500000000000000000
       Other Current Assets 
0
225
331
1,180
1,650
1,186
919
808
985
1,035
931
980
1,388
1,184
996
1,598
1,036
1,015
1,218
1,266
1,763
2,379
2,568
1,748
1,648
2,451
1,948
2,312
6,767
9,406
0
19,519
0
0
0
00019,51909,4066,7672,3121,9482,4511,6481,7482,5682,3791,7631,2661,2181,0151,0361,5989961,1841,3889809311,0359858089191,1861,6501,1803312250
   > Long-term Assets 
0
129,944
130,187
130,069
130,069
130,132
130,129
130,125
130,187
138,811
138,796
137,792
137,785
137,779
137,774
96,698
95,447
92,925
100,042
97,544
109,479
106,121
102,764
99,406
96,682
93,958
91,370
90,506
87,749
85,032
0
79,513
76,755
73,995
71,236
71,23673,99576,75579,513085,03287,74990,50691,37093,95896,68299,406102,764106,121109,47997,544100,04292,92595,44796,698137,774137,779137,785137,792138,796138,811130,187130,125130,129130,132130,069130,069130,187129,9440
       Property Plant Equipment 
0
0
118
0
0
63
60
56
118
103
88
93
86
80
75
68
1,205
1,072
938
804
697
558
420
282
142
3
0
1,721
1,549
1,417
1,198
1,068
895
720
546
5467208951,0681,1981,4171,5491,721031422824205586978049381,0721,2056875808693881031185660630011800
       Goodwill 
0
0
0
130,069
130,069
130,069
130,069
130,069
130,069
138,708
138,708
0
0
0
0
0
0
0
99,104
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000099,1040000000138,708138,708130,069130,069130,069130,069130,069130,069000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
137,699
137,699
137,699
137,699
96,630
94,242
91,853
0
96,740
108,782
105,563
102,344
99,125
96,540
93,955
91,370
88,785
86,200
83,615
81,030
78,445
75,860
73,275
70,690
70,69073,27575,86078,44581,03083,61586,20088,78591,37093,95596,54099,125102,344105,563108,78296,740091,85394,24296,630137,699137,699137,699137,69900000000000
> Total Liabilities 
0
427
711
2,293
2,885
2,401
1,683
1,994
2,721
2,150
1,875
2,349
2,866
2,105
2,367
11,555
12,590
23,664
22,699
19,617
28,230
21,828
20,081
22,812
53,665
25,719
23,974
48,894
45,366
44,069
52,109
44,190
24,761
24,755
25,329
25,32924,75524,76144,19052,10944,06945,36648,89423,97425,71953,66522,81220,08121,82828,23019,61722,69923,66412,59011,5552,3672,1052,8662,3491,8752,1502,7211,9941,6832,4012,8852,2937114270
   > Total Current Liabilities 
0
427
711
2,293
2,885
2,401
1,683
1,994
2,721
2,150
1,875
2,349
2,866
2,105
2,367
11,555
11,823
22,897
21,932
19,487
28,097
21,698
19,951
22,812
20,249
25,723
23,974
47,874
44,516
43,219
51,259
43,848
24,759
24,753
25,327
25,32724,75324,75943,84851,25943,21944,51647,87423,97425,72320,24922,81219,95121,69828,09719,48721,93222,89711,82311,5552,3672,1052,8662,3491,8752,1502,7211,9941,6832,4012,8852,2937114270
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,641
0
0
0
10,262
0
0
0
30,704
0
0
0
16,743
0
0
0
00016,74300030,70400010,26200010,6410000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
0
0
0
10,000
0
0
0
30,045
0
0
0
16,068
0
0
0
00016,06800030,04500010,00000010,0000000000000000000000
       Accounts payable 
0
0
0
906
0
0
0
455
0
0
0
784
0
0
0
755
0
0
0
2,726
0
0
0
6,525
0
0
0
8,631
0
0
0
9,646
0
0
0
0009,6460008,6310006,5250002,726000755000784000455000906000
       Other Current Liabilities 
0
427
711
1,387
2,885
2,401
1,683
1,539
2,721
2,150
1,875
1,565
2,866
2,105
2,367
10,800
11,823
22,897
21,932
6,120
28,097
21,698
19,951
6,025
20,249
25,723
23,974
963
44,516
43,219
51,259
10,886
0
24,753
0
024,753010,88651,25943,21944,51696323,97425,72320,2496,02519,95121,69828,0976,12021,93222,89711,82310,8002,3672,1052,8661,5651,8752,1502,7211,5391,6832,4012,8851,3877114270
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
767
767
767
130
133
130
130
0
33,416
-4
0
1,020
850
850
0
342
2
2
2
22234208508501,0200-433,41601301301331307677677670000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,020
848
848
848
342
0
0
0
0003428488488481,020000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
767
767
0
130
130
130
130
0
0
0
1,020
848
0
848
0
0
0
0
000084808481,020000130130130130076776700000000000000000
> Total Stockholder Equity
0
179,160
178,247
174,589
170,746
166,293
163,169
160,039
156,898
159,962
158,719
153,521
149,680
145,185
141,477
94,700
92,602
84,711
87,451
82,108
99,458
106,458
104,535
109,591
92,892
110,376
95,212
69,413
72,142
57,659
39,311
76,079
70,717
60,630
50,689
50,68960,63070,71776,07939,31157,65972,14269,41395,212110,37692,892109,591104,535106,45899,45882,10887,45184,71192,60294,700141,477145,185149,680153,521158,719159,962156,898160,039163,169166,293170,746174,589178,247179,1600
   Common Stock
0
0
0
500
0
0
0
500
0
0
0
513
513
513
513
513
513
513
535
535
646
741
804
863
863
863
863
863
995
995
39,311
1,306
1,306
1,306
1,775
1,7751,3061,3061,30639,311995995863863863863863804741646535535513513513513513513513000500000500000
   Retained Earnings Total Equity00000000000000000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000000000000000
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
179,682
0
0
0
174,089
0
0
0
165,022
185,165
185,165
185,165
185,165
185,165
185,165
195,047
195,043
109,841
106,458
-4
238,422
108,738
108,735
108,774
238,421
91,405
91,432
39,311
173,038
74,809
74,832
75,227
75,22774,83274,809173,03839,31191,43291,405238,421108,774108,735108,738238,422-4106,458109,841195,043195,047185,165185,165185,165185,165185,165185,165165,022000174,089000179,682000



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,356
Cost of Revenue--
Gross Profit-9,356
 
Operating Income (+$)
Gross Profit-
Operating Expense-42,658
Operating Income-33,302-42,658
 
Operating Expense (+$)
Research Development31,616
Selling General Administrative11,065
Selling And Marketing Expenses-
Operating Expense42,65842,681
 
Net Interest Income (+$)
Interest Income-
Interest Expense--
Other Finance Cost-5,431
Net Interest Income-5,431
 
Pretax Income (+$)
Operating Income-33,302
Net Interest Income-5,431
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-39,110-33,302
EBIT - interestExpense = 0
-39,209
-39,209
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--39,110
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-39,110
Tax Provision-99
Net Income From Continuing Ops-39,209-39,209
Net Income-39,209
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-5,431
 

Technical Analysis of Klaria
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Klaria. The general trend of Klaria is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Klaria's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Klaria Pharma Holding AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.411 < 0.416 < 0.424.

The bearish price targets are: 0.235.

Tweet this
Klaria Pharma Holding AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Klaria Pharma Holding AB. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Klaria Pharma Holding AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Klaria Pharma Holding AB. The current macd is -0.03114927.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Klaria price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Klaria. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Klaria price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Klaria Pharma Holding AB Daily Moving Average Convergence/Divergence (MACD) ChartKlaria Pharma Holding AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Klaria Pharma Holding AB. The current adx is 23.70.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Klaria shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Klaria Pharma Holding AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Klaria Pharma Holding AB. The current sar is 0.60315704.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Klaria Pharma Holding AB Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Klaria Pharma Holding AB. The current rsi is 34.54. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Klaria Pharma Holding AB Daily Relative Strength Index (RSI) ChartKlaria Pharma Holding AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Klaria Pharma Holding AB. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Klaria price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Klaria Pharma Holding AB Daily Stochastic Oscillator ChartKlaria Pharma Holding AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Klaria Pharma Holding AB. The current cci is -144.2607237.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Klaria Pharma Holding AB Daily Commodity Channel Index (CCI) ChartKlaria Pharma Holding AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Klaria Pharma Holding AB. The current cmo is -47.10349728.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Klaria Pharma Holding AB Daily Chande Momentum Oscillator (CMO) ChartKlaria Pharma Holding AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Klaria Pharma Holding AB. The current willr is -64.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Klaria is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Klaria Pharma Holding AB Daily Williams %R ChartKlaria Pharma Holding AB Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Klaria Pharma Holding AB.

Klaria Pharma Holding AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Klaria Pharma Holding AB. The current atr is 0.07557928.

Klaria Pharma Holding AB Daily Average True Range (ATR) ChartKlaria Pharma Holding AB Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Klaria Pharma Holding AB. The current obv is -12,024,287.

Klaria Pharma Holding AB Daily On-Balance Volume (OBV) ChartKlaria Pharma Holding AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Klaria Pharma Holding AB. The current mfi is 31.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Klaria Pharma Holding AB Daily Money Flow Index (MFI) ChartKlaria Pharma Holding AB Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Klaria Pharma Holding AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-10-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-10-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-10-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-25BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-31STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-18MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Klaria Pharma Holding AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Klaria Pharma Holding AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5034.543
Ma 20Greater thanMa 500.502
Ma 50Greater thanMa 1000.529
Ma 100Greater thanMa 2000.499